Patents by Inventor Kinneret Savitzky

Kinneret Savitzky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Splice variants of CD40-receptor
    Patent number: 6994994
    Abstract: The present invention concerns six novel variants of alternative splicing of the CD40 receptor.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: February 7, 2006
    Assignee: Compugent LTD
    Inventors: Kinneret Savitzky, Rami Khosravi, Menashe Elazar
  • Splice variants of CD40-receptor
    Publication number: 20050244877
    Abstract: The present invention concerns six novel variants of alternative splicing of the CD40 receptor.
    Type: Application
    Filed: May 18, 2005
    Publication date: November 3, 2005
    Inventors: Kinneret Savitzky, Rami Khosravi, Menashe Elazar
  • Alternative splice variants
    Publication number: 20040258681
    Abstract: The invention concerns novel nucleic acid sequences and amino acid sequences obtained by alternative splicing, expression vectors, host cell and pharmaceutical compositions comprising said sequences.
    Type: Application
    Filed: February 20, 2004
    Publication date: December 23, 2004
    Applicant: Compugen Ltd. Corporation
    Inventors: Kinneret Savitzky, Liat Mintz, Sharon Engel, Jeanne Bernstein
  • Novel nucleic acid and amino acid sequences
    Publication number: 20040219583
    Abstract: The invention concerns novel nucleic acid sequences, amino acid sequences coded thereby and method of detection using the above. The novel nucleic acid sequences are naturally occurring splice variants of a prostate specific antigen sequence (PSA) or of the KLK-2 gene.
    Type: Application
    Filed: March 16, 2004
    Publication date: November 4, 2004
    Applicant: Compugen Ltd.
    Inventors: Kinneret Savitzky, Liat Mintz, Anat David, Idit Azar
  • Variant of TNF-receptor
    Publication number: 20040170975
    Abstract: The invention concerns nucleic acid and amino acid sequences of variants of TNF-receptor obtained by alternative splicing. The invention also concerns expression vectors, host cells, pharmaceutical compositions, and detection assays making use of these sequences, as well as antibodies reactive with the sequences.
    Type: Application
    Filed: February 28, 2002
    Publication date: September 2, 2004
    Applicant: Compugen Ltd.
    Inventors: Kinneret Savitzky, Amir Toporik, Sharon Biton
  • VEGF nucleic acid and amino acid sequences
    Patent number: 6783954
    Abstract: The invention concerns novel nucleic acid sequences and amino acid sequences of a novel variant of vascular endothelial growth factor (VEGF). The invention further concerns expression vectors and host cells containing said sequences as well as pharmaceutical compositions and detection methods using said sequences.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: August 31, 2004
    Assignee: Compugen Ltd.
    Inventors: Liat Mintz, Kinneret Savitzky, Sharon Engel
  • Nucleic acid and amino acid sequences
    Patent number: 6740516
    Abstract: An isolated nucleic acid sequence depicted in SEQ ID NO:6 is an alternative splice variant of human kallikrien-2 gene (KLK-2). An expression vector containing the splice variant and a host cell transfected by the expression vector are provided. The nucleic acid is useful for determining the level of nucleic acid sequences of human kallikrien variants in a biological sample.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: May 25, 2004
    Assignee: Compugen Ltd.
    Inventors: Kinneret Savitzky, Liat Mintz, Anat David, Idit Azar
  • Alternative splice variants of CD40
    Patent number: 6720182
    Abstract: The invention concerns novel nucleic acid sequences and amino acid sequences obtained by alternative splicing, expression vectors, host cell and pharmaceutical compositions comprising said sequences.
    Type: Grant
    Filed: May 10, 2000
    Date of Patent: April 13, 2004
    Assignee: Compugen Ltd. Corporation
    Inventors: Kinneret Savitzky, Liat Mintz, Sharon Engel, Jeanne Bernstein
  • Novel nucleic acid and amino acid sequences
    Publication number: 20030207808
    Abstract: The invention concerns novel nucleic acid sequences, amino acid sequences coded thereby and method of detection using the above. The novel nucleic acid sequences are naturally occurring splice variants of a prostate specific antigen sequence (PSA) or of the KLK-2 gene.
    Type: Application
    Filed: November 19, 2002
    Publication date: November 6, 2003
    Inventors: Kinneret Savitzky, Liat Mintz, Anat David, Idit Azar
  • PI3K - regulatory subunit homology
    Publication number: 20030125288
    Abstract: The invention concerns novel nucleic acid and amino acid sequences which are homologs of the PI3K-regulatory subunits. The invention also concerns pharmaceutical compositions containing these sequences as well as methods of detection using the sequences.
    Type: Application
    Filed: September 30, 2002
    Publication date: July 3, 2003
    Inventors: Idit Azar, Zurit Levine, Jeanne Bernstein, Kinneret Savitzky
  • Novel nucleic acid and amino acid sequences
    Publication number: 20030125295
    Abstract: The invention concerns novel nucleic acid sequences and amino acid sequences of a novel variant of vascular endothelial growth factor (VEGF). The invention further concerns expression vectors and host cells containing said sequences as well as pharmaceutical compositions and detection methods using said sequences.
    Type: Application
    Filed: November 19, 2002
    Publication date: July 3, 2003
    Applicant: Compugen Ltd.
    Inventors: Liat Mintz, Kinneret Savitzky, Sharon Engel
  • StAR homologues
    Publication number: 20030105049
    Abstract: The invention concerns novel nucleic acid and amino acid sequences which are homologues to steroidogenic acute regulatory protein. The invention further concerns expression vectors comprising these sequences and host cells transfected with the vectors. The invention further concerns pharmaceutical compositions.
    Type: Application
    Filed: May 15, 2002
    Publication date: June 5, 2003
    Inventors: Kinneret Savitzky, Liat Mintz
  • Variant of vascular endothelial growth factor
    Patent number: 6506884
    Abstract: The invention concerns novel nucleic acid sequences and amino acid sequences of a novel variant of vascular endothelial growth factor (VEGF). The invention further concerns expression vectors and host cells containing said sequences as well as pharmaceutical compositions and detection methods using said sequences.
    Type: Grant
    Filed: March 6, 2000
    Date of Patent: January 14, 2003
    Assignee: Compugen Ltd.
    Inventors: Liat Mintz, Kinneret Savitzky, Sharon Engel
  • Novel nucleic acid and amino acid sequences
    Publication number: 20020103149
    Abstract: The invention concerns novel nucleic acid sequences and amino acid sequences of a novel variant of vascular endothelial growth factor (VEGF). The invention further concerns expression vectors and host cells containing said sequences as well as pharmaceutical compositions and detection methods using said sequences.
    Type: Application
    Filed: June 20, 2001
    Publication date: August 1, 2002
    Inventors: Liat Mintz, Kinneret Savitzky, Sharon Engel
  • Novel nucleic acid and amino acid sequences
    Publication number: 20020099189
    Abstract: The invention concerns novel nucleic acid sequences, amino acid sequences coded thereby and method of detection using the above. The novel nucleic acid sequences are naturally occurring splice variants of a prostate specific antigen sequence (PSA) or of the KLK-2 gene.
    Type: Application
    Filed: January 8, 2001
    Publication date: July 25, 2002
    Inventors: Kinneret Savitzky, Liat Mintz, Anat David, Idit Azar
  • Splice variant of mGluR
    Publication number: 20020081655
    Abstract: The present invention provides nucleic acid sequences, of an alternative splicing variant of metabotropic glutamate receptor (mGluR). The invention also provides amino acid sequences coded by the isolated nucleic sequences purified antibodies, which binds specifically to the amino acid sequences, and expression vectors comprising any one of the nucleic acid sequences. The invention also provides pharmaceutical compositions comprising as an active ingredient the expression vector or an amino acid sequence.
    Type: Application
    Filed: June 4, 2001
    Publication date: June 27, 2002
    Inventors: Kinneret Savitzky, Amir Toporik, Liat Mintz
  • Sequences of trail variants
    Publication number: 20020061525
    Abstract: The present invention concerns novel, naturally occurring splice variants of the TNF-related apoptosis inducing ligand (TRAIL). Provided are coding nucleic acid sequences and the polypeptides encoded thereby, vectors and host cells containing said nucleic acid sequences and antibodies reactive with said polypeptides. The invention also concerns pharmaceutical compositions for the treatment of certain diseases, comprising the nucleic acid sequences, the amino acid sequences, the expression vectors or the antibodies.
    Type: Application
    Filed: May 16, 2001
    Publication date: May 23, 2002
    Inventors: Rodrigo Yelin, Rami Khosravi, Kinneret Savitzky